You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HBV RNA

Showing 1 - 25 of 2,398
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Dynamic Changes of Serum HBV RNA in Chronic Hepatitis B Patients

Not yet recruiting
  • Chronic Hepatitis B Patients
    • Beijing, Beijing, China
      Beijing Friendship Hospital, Capital Medical University
    Aug 15, 2023

    Single-cell RNA Sequencing Resolves Regulatory Role of HBV on

    Recruiting
    • HBV
    • Primary Liver Cancer
    • HBV DNA Sequencing
    • Wuhan, Hubei, China
      Zhongnan Hospital of Wuhan University
    Dec 22, 2022

    Long Non-coding RNA SNHG15 asNovel Biomarker in HBV Associated

    Not yet recruiting
    • HCC
    • No intervention was required for patients or control group in this study
    • (no location specified)
    Apr 21, 2023

    Chronic Hepatitis B Virus Infection Manage

    Completed
    • Chronic HBV Infection
    • Drug Withdrawal
    • serum HBV RNA
    • (no location specified)
    Jan 30, 2021

    Screening for the Presence of HIV-1, RNA and HBV DNA in Blood Donations Trial in Taipei (Blood test)

    Completed
    • Screening for the Presence of HIV-1, RNA and HBV DNA in Blood Donations
    • Blood test
    • Taipei, Taiwan
      Taipei Blood Center Taiwan Blood Service Foundation (TBSF)
    Feb 17, 2021

    Chronic Hepatitis b Trial in Lyon (procedure, biological, other)

    Not yet recruiting
    • Chronic Hepatitis b
    • Investigation of the intrahepatic compartment using the fine needle aspiration (FNA) technique
    • +2 more
    • Lyon, France
      Hepatology Department - Hospices Civils de Lyon
    Sep 14, 2023

    Chronic Hepatitis B and Hepatitis D Co-infection Trial in Changchun (HH-003 20mg/kg, HH-003 3mg/kg)

    Active, not recruiting
    • Chronic Hepatitis B and Hepatitis D Co-infection
    • HH-003 20mg/kg
    • HH-003 3mg/kg
    • Changchun, Jilin, China
      First Hospital of Jilin University
    Dec 30, 2022

    HBV pgRNA on Long-term Outcomes in Hepatitis B Patients Treated

    Not yet recruiting
    • HBV
    • HCC
    • nucleoside analogues or interferon
    • Hefei, Anhui, China
    • +9 more
    Jul 20, 2023

    Study of Serum Tumor Markers of HBV Associated HCC

    Not yet recruiting
    • HCC
    • tumor tissue and blood tests
    • (no location specified)
    Apr 10, 2023

    Chronic Hepatitis B Trial run by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (VIR-2218 and

    Not yet recruiting
    • Chronic Hepatitis B
    • VIR-2218 and peginterferon alfa-2a
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Oct 27, 2023

    DELTA DESCRIBE: THE FRENCH COLLABORATIVE PROJECT

    Recruiting
    • Hepatitis D
    • Patients co-infected HBV/HDV
    • Limoges, France
      Chu Limoges
    Jun 27, 2023

    Chronic Hepatitis b Trial in Hong Kong (RBD1016, Placebo, Entecavir)

    Recruiting
    • Chronic Hepatitis b
    • Hong Kong, China
      The University of Hong Kong
    Apr 24, 2022

    Dissection of Molecular and Immunological Interaction in HCC of

    Not yet recruiting
    • Hepatocellular Carcinoma
      • Tainan, Taiwan
      • +2 more
      Nov 6, 2022

      Hepatitis B, Chronic Trial in Worldwide (IMC-I109V-101 Single Ascending Dose, IMC-I109V-101 Multiple Ascending Doses)

      Recruiting
      • Hepatitis B, Chronic
      • IMC-I109V-101 Single Ascending Dose
      • IMC-I109V-101 Multiple Ascending Doses
      • Los Angeles, California
      • +19 more
      May 10, 2023

      Hepatitis B, Chronic Trial in Changchun (drug, other, combination product)

      Not yet recruiting
      • Hepatitis B, Chronic
      • Changchun, Jilin, China
        The First Hospital of Jilin University
      Jul 29, 2022

      Thailand HDV Cohort

      Not yet recruiting
      • HDV
        • Bangkok, Thailand
        • +3 more
        May 1, 2022

        Patients With Hepatitis D Virus (HDV) Infection in China

        Not yet recruiting
        • Hepatitis D
          • Beijing, Beijing, China
            Bejing Tsinghua Changgung Hospital
          Jul 7, 2022

          Viral Hepatitis B, Viral Hepatitis D, Cirrhosis, Liver Trial in Worldwide (REP 2139-Mg, Tenofovir Disoproxil Fumarate, Pegylated

          Available
          • Viral Hepatitis B
          • +6 more
          • REP 2139-Mg
          • +2 more
          • Vienna, Austria
          • +12 more
          Feb 1, 2023

          Australian Hepatitis and Risk Survey in Prisons

          Recruiting
          • Hepatitis C
          • +2 more
          • Point-of-care hepatitis C antibody test
          • +5 more
          • Hume, Australian Capital Territory, Australia
          • +23 more
          Apr 20, 2023

          Chronic Hepatitis B Trial in Hong Kong, Auckland (VRON-0200-AdC6, VRON-0200-AdC7)

          Recruiting
          • Chronic Hepatitis B
          • VRON-0200-AdC6
          • VRON-0200-AdC7
          • Hong Kong, Hong Kong
          • +1 more
          Oct 6, 2023

          NSCLC Stage IV, HIV, HBV Trial in Verona (Nivolumab and Ipilimumab)

          Not yet recruiting
          • NSCLC Stage IV
          • +4 more
          • Nivolumab and Ipilimumab
          • Verona, Veneto/Verona, Italy
            Centro Ricerche Cliniche
          Oct 26, 2022

          Acceptability for HIV-1 and Hepatitis B (TINIES for BBVs)

          Not yet recruiting
          • HIV Infections
          • Hepatitis B
          • Doctors Laboratory TINIES small volume blood testing kit
          • (no location specified)
          Jan 10, 2023

          Liver Cancer, Hepatocellular Carcinoma Trial in Chengdu (HBV mRNA vaccine)

          Recruiting
          • Liver Cancer
          • Hepatocellular Carcinoma
          • HBV mRNA vaccine
          • Chengdu, Sichuan, China
            West China Hospital, Sichuan University
          Feb 12, 2023

          HIV-1/HBV Co-Infection Trial in Worldwide (B/F/TAF, Placebo to match DTG, Placebo to match F/TDF)

          Active, not recruiting
          • HIV-1/HBV Co-Infection
          • Fort Pierce, Florida
          • +66 more
          Sep 19, 2022

          Chronic Hepatitis B Trial (Imdusiran (AB-729))

          Not yet recruiting
          • Chronic Hepatitis B
          • Imdusiran (AB-729)
          • (no location specified)
          Nov 30, 2023